Skip to content

ArriVent BioPharma

US · AVBP #3057 by market cap Listed 2024
10.52 -0.74 -6.57%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About ArriVent BioPharma

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.

Founded
2021
CEO
Dr. Zhengbin Yao, PhD
Employees
77
Headquarters
Newtown Square, Pennsylvania, United States of America
Fiscal year end
12-31
Website
arrivent.com

Company profile

Exchange
US
Symbol
AVBP
Market-cap rank
#3057
Listing date
2024-01-26
Market cap
544.13M
Float cap
331.50M
Shares out
51.72M
Float shares
31.51M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

ArriVent BioPharma discussion 0 comments

Add a comment